Peretto, G., Merlo, M., Ambrosi, A., Bacigalupi, E., Villatore, A., Molinari, L., Anguera, I., Claver, E., Dal Ferro, M., Suwalski, P., Spartalis, M., Verdonschot, J., Ciabatti, M., Martini, N., Zampieri, M., Paldino, A., Valeri, Y., Radesich, C., Lazzeroni, D., ... Sinagra, G. (2026). Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score. European Heart Journal, 47(1), 94-106. Article ehaf477. https://doi.org/10.1093/eurheartj/ehaf477

Venner, M. F. G. H. M., Verdonschot, J. A. J., & Knackstedt, C. (2026). Letter to the editor: Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 442, Article 133886. https://doi.org/10.1016/j.ijcard.2025.133886

Mourmans, S. G. J., Achten, A., Weerts, J., Scheepers, M., Barandiarán Aizpurua, A., Henkens, M., Uszko-Lencer, N., Brunner-La Rocca, H.-P., Knackstedt, C., & van Empel, V. P. M. (2026). The diagnostic yield of an elaborate workup for comorbidities in a real-life heart failure with preserved ejection fraction outpatient population. European Journal of Preventive Cardiology, 33(2), 276-285. https://doi.org/10.1093/eurjpc/zwaf429

Johnson, R., Fletcher, R. A., Peters, S., Ohanian, M., Soka, M., Smolnikov, A., Abihider, K. E., Ackerman, M. J., Ader, F., Akhtar, M. M., Amin, A. S., Ashley, E. A., Atherton, J. J., Austin, R., Baas, A. F., Bagnall, R. D., Ross, S. B., Blouin, J.-L., Brown, E. E., ... Australian Genomics Cardiac Flagship (2025). Titin-related familial dilated cardiomyopathy: factors associated with disease onset. European Heart Journal, 46(48), 5240-5257. https://doi.org/10.1093/eurheartj/ehaf380

Steiner, B., Neumann, A., Schwertfeger, M., Verket, M., Romero, I., Hurtado, C., Schiefel, V., McNulty, A., Sankarpandi, S., Gingele, A. J., Helms, T. M., Brunner-La Rocca, H.-P., Zippel-Schultz, B., & iCARE4CVD Consortium (2025). Patient-reported outcome and experience measures in cardiovascular disease: a scoping review as part of iCARE4CVD. Journal of patient-reported outcomes, 9(1), Article 141. https://doi.org/10.1186/s41687-025-00980-4

Faassen, I. M. E., Heijligers, M., Weijermans, N. H. N., van Buul-van Zwet, M. L., Zietse, C. S., Zamani Esteki, M., Paulussen, A. D. C., & Verdonschot, J. A. J. (2025). Preimplantation genetic testing for cardiomyopathies: a case series illustrating the clinical and technological perspective. European Heart Journal - Case Reports, 9(12), Article ytaf630. https://doi.org/10.1093/ehjcr/ytaf630

Weerts, J., Aizpurua, A. B., Patel, R. B., van de Bovenkamp, A. A., Amin, H., Sanders-van Wijk, S., Mourmans, S. G. J., Achten, A., Handoko, M. L., Bayes-Genis, A., Brunner-La Rocca, H.-P., Shah, S. J., Knackstedt, C., & van Empel, V. P. M. (2025). A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptides. European journal of heart failure, 27(12), 2897-2902. https://doi.org/10.1002/ejhf.3651

Hoes, M. F., Wang, S., & Luiken, J. J. F. P. (2025). Endosomal Mechanisms in Heart Failure Pathophysiology. Current Heart Failure Reports, 22(1), Article 38. https://doi.org/10.1007/s11897-025-00728-7

Gingele, A. J., Eurlings, C., Boyne, J. J., & Brunner-La Rocca, H.-P. (2025). Identifying patients' signs and symptoms to guide eHealth-directed diuretic therapy intensification in heart failure-Insights from the trial of intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF). Wiener Klinische Wochenschrift, 137(23-24), 774-777. https://doi.org/10.1007/s00508-025-02551-5

Stroeks, S. L. V. M., Wang, P., Merlo, M., Muller, S., Paldino, A., Mora-Ayestaran, N., Jason, M., Ferro, M. D., Loca, C. P., Dominguez, F., Gonzalez-Lopez, E., van den Wijngaard, A., Venner, M. F. G. H. M., Sikking, M., Minten, M., Nihant, B., Beelen, N., Graw, S., Medo, K., ... Verdonschot, J. A. J. (2025). Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy. European journal of heart failure, 27(12), 3205-3218. https://doi.org/10.1002/ejhf.70040

Malgie, J., Wilde, M. I., Koudstaal, S., Denham, R., da Fonseca, C. A., Swart, H. P., van Ofwegen, C. E. E., Yilmaz, A., Pisters, R., Linssen, G. C. M., Faber, N., van Heerebeek, L., van de Swaluw, J. E. C., de Boer, R. A., Brunner-La Rocca, H.-P., & Brugts, J. J. (2025). Real-life implementation of guideline-recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE-HF. European journal of heart failure, 27(12), 2735-2746. https://doi.org/10.1002/ejhf.70006

Li, X., Achten, A., Nassiri, S., Mourmans, S., van de Bovenkamp, A. A., Knackstedt, C., Handoko, M. L., Weerts, J., & van Empel, V. (2025). Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohorts. Netherlands Heart Journal, 33(12), 412-420. https://doi.org/10.1007/s12471-025-02000-y

Achten, A., Peeters, L., Verkoulen, G., Weerts, J., Knackstedt, C., Boerma, E.-J., van Empel, V., & Wijk, S. S. (2025). Time to screen: rationale and roadmap for HFpEF screening in individuals with obesity. Heart Failure Reviews, 30(6), 1207-1213. https://doi.org/10.1007/s10741-025-10540-z

Verdonschot, J. A. J., Kaski, J. P., Asselbergs, F. W., Behr, E. R., Charron, P., Dawson, D., Haugaa, K. H., Kuchynka, P., Lopes, L. R., Mazzanti, A., Monserrat, L., Pantazis, A., Prasad, S. K., Schunkert, H., Seferovic, P. M., Sheppard, M. N., Sinagra, G., van Tintelen, J. P., Tome Esteban, M. T., ... Garcia-Pavia, P. (2025). Clinical care of family members of patients with dilated cardiomyopathy: A clinical consensus statement of the Heart Failure Association of the European Society of Cardiology, the European Society of Cardiology Working Group on Myocardial & Pericardial Diseases, and the European Society of Cardiology Council on Cardiovascular Genomics. European Heart Journal, 46(43), 4569-4582. Article ehaf571. https://doi.org/10.1093/eurheartj/ehaf571

Lagrange, J., Jahangiri, M., Baudry, G., Monzo, L., Guerci, P., ter Maaten, J. M., Heymans, S., Mercier, N., & Girerd, N. (2025). Updates on the endothelial glycocalyx in heart failure with preserved ejection fraction. American Journal of Physiology-heart and Circulatory Physiology, 329(5), H1316-H1330. https://doi.org/10.1152/ajpheart.00410.2025

Deltadahl, S., Gilbey, J., Van Laer, C., Boeckx, N., Leers, M. P. G., Freeman, T., Aiken, L., Farren, T., Smith, M., Zeina, M., MacDonald, S., Gleghorn, D., Rudd, J. H. F., Ouwehand, W. H., Amenga-Etego, L., Sarpong, K., Awandare, G. A., Trompeter, S., Gupta, R., ... BloodCounts! consortium (2025). Deep generative classification of blood cell morphology. Nature Machine Intelligence, 7(11), 1791-1803. https://doi.org/10.1038/s42256-025-01122-7

Venner, M. F. G. H. M., Heymans, A. B. M., Beelen, N. J., Stroeks, S. L. V. M., Faassen, I. M. E., Sikking, M. A., Henkens, M. T. H. M., Van Der Crabben, S. N., Raafs, A. G., Heymans, S. R. B., & Verdonschot, J. A. J. (2025). Predictive value of ambulatory ECG monitoring for malignant arrhythmic events in genetic dilated cardiomyopathy. EP Europace, 27(11), Article euaf279. https://doi.org/10.1093/europace/euaf279

Stroeks, S. L. V. M., Merlo, M., Mora-Ayestaran, N., Jason, M., Tayal, U., Wang, P., Cannatà, A., Sikking, M. A., Dal Ferro, M., Peiro, B., Willemars, M., Hellebrekers, D. M. E. I., van Leeuwen, R. E. W., Setti, M., Gonzalez-Lopez, E., Krapels, I. P. C., Pio Loco Detto Gava, C., van den Wijngaard, A., Henkens, M. T. H. M., ... Verdonschot, J. A. J. (2025). Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy. Circulation-Heart Failure, 18(11), e012592. Article 012592. https://doi.org/10.1161/CIRCHEARTFAILURE.124.012592

Vermeulen, C., van Geloven, N., Mertens, B., Spelmink, S. E., Schipperus, M. R., Janssen, M. P., Kerkhoffs, J.-L. H., den Besten, G., van den Bos, A. G., Korver-Keularts, I. M. L. W., van de Kerkhof, D., Klinkspoor, H. J. H., De Vooght, K. M. K., van Gammeren, A. J., Russcher, H., Heijnen, J. W. M., de Korte, D., van Der Meer, P. F., & Klei, T. R. L. (2025). Clinical evaluation of red cell concentrates in non-DEHP plasticized containers compared with standard DEHP plasticized containers: A quasi-randomized observational multicentre study. Vox Sanguinis, 120(11), 1183-1188. https://doi.org/10.1111/vox.70019

Tingen, H. S. A., Berends, M., Tubben, A., van der Meer, P., Slart, R. H. J. A., Bijzet, J., van der Zwaag, P. A., Kimmich, C., Knackstedt, C., Muntinghe, F. L. H., Houwerzijl, E. J., Hazenberg, B. P. C., & Nienhuis, H. L. A. (2025). Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy. European Journal of Nuclear Medicine and Molecular Imaging, 52(13), 5000-5005. https://doi.org/10.1007/s00259-025-07328-6

Gigli, M., Verdonschot, J. A. J., Garcia-Pavia, P., Stolfo, D., Monserrat, L., Prasad, S., Mazzanti, A., Asselbergs, F. W., Bauce, B., Charron, P., Dawson, D., Halliday, B. P., Mestroni, L., Seferovic, P., Tayal, U., Esteban, M. T. T., Van Tintelen, P., Heymans, S., Pantazis, A., ... Sinagra, G. (2025). Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC. European journal of heart failure, 27(11), 2229-2243. https://doi.org/10.1002/ejhf.70042

Setti, M., Iseppi, M., Verdonschot, J. A. J., Rizzi, J. G., Paldino, A., Gava, C. P. L. D., Barbati, G., Dal Ferro, M., Venner, M. F. G. H. M., Raafs, A. G., Gigli, M., Stolfo, D., De Luca, A., De Angelis, G., Capovilla, T. M., Graw, S., Ribichini, F. L., Taylor, M., Mestroni, L., ... Merlo, M. (2025). Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy. European journal of heart failure, 27(11), 2571-2581. Article 3671. https://doi.org/10.1002/ejhf.3671

Chua, A. P. A., Weerts, J., Achten, A., Nabeta, T., Sarrazyn, C., Lopez-Santi, P., Mourmans, S. G. J., Su, J. L., Bax, J. J., Knackstedt, C., van Empel, V. P. M., & Ajmone-Marsan, N. (2025). Left Atrial Strain Index in Patients with Heart Failure with Preserved Ejection Fraction. Journal of the American Society of Echocardiography, 38(11), 1099-1101. https://doi.org/10.1016/j.echo.2025.07.008

Beverborg, N. G., Alnuwaysir, R. I. S., Markousis-Mavrogenis, G., Hoes, M. F., van Der Wal, H. H., Romaine, S. P. R., Nath, M., Koekoemoer, A., Cleland, J. G. F., Lang, C. C., Anker, S. D., Dickstein, K., Metra, M., Ng, L. L., van Veldhuisen, D. J., Voors, A. A., Samani, N. J., & van Der Meer, P. (2025). The transcriptional profile of iron deficiency in patients with heart failure: Heme-sparing and reduced immune processes. European journal of heart failure, 27(11), 2313-2324. https://doi.org/10.1002/ejhf.3562

Schoonvelde, S. A. C., Nollet, E. E., Zwetsloot, P. P., Knackstedt, C., Germans, T., Hirsch, A., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., van der Velden, J., & Michels, M. (2025). Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression. International Journal of Cardiology, 437, Article 133444. https://doi.org/10.1016/j.ijcard.2025.133444

Heymans, A. B. M., Bianchi, L., Volders, P. G. A., van der Crabben, S. N., & Verdonschot, J. A. J. (2025). SCN5A Cardiomyopathy: from Ion Channel Dysfunction To Clinical Disease. Current Cardiology Reports, 27(1), Article 138. https://doi.org/10.1007/s11886-025-02298-5

Sikking, M., Wiethoff, I., Henkens, M., Evers, S., Stroeks, S., Venner, M., Weerts, J., Brunner-la Rocca, H.-P., Knackstedt, C., van Empel, V., Michels, M., Heymans, S., Hiligsmann, M., & Verdonschot, J. (2025). High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Quality of Life Research, 34(10), 2901-2910. https://doi.org/10.1007/s11136-025-04027-5

Perotto, M., Paldino, A., Mazzarotto, F., Barbati, G., Stroeks, S. L. V. M., Verdonschot, J. A. J., Akhtar, M., Elliott, P., Ochoa, J. P., Garcia-Pavia, P., de Frutos, F., Sepp, R., Hategan, L., Prasad, S., Yazdani, M., Morris-Rosendahl, D., Palinkas, E. D., Girolami, F., Olivotto, I., ... Dal Ferro, M. (2025). Genetic and Phenotypic Characterization of Nexilin (NEXN)–Related Cardiomyopathy: Results From a Multicentric Study. JACC: Heart Failure, 13(9), Article 102529. https://doi.org/10.1016/j.jchf.2025.102529

Gilani, K., Verket, M., Peters, C., Dumontier, M., Rocca, H. P. B. L., & Urovi, V. (2025). CDE-Mapper: Using retrieval-augmented language models for linking clinical data elements to controlled vocabularies. Computers in Biology and Medicine, 196, Article 110745. https://doi.org/10.1016/j.compbiomed.2025.110745

Slob, B. P. H., Postma, M. J., Weersma, M., Rocca, H.-P. B.-L., de Jong, L. A., & Boersma, C. (2025). Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands. American journal of cardiovascular drugs : drugs, devices, and other interventions, 25(5), 715-726. https://doi.org/10.1007/s40256-025-00749-6

Aukes, R., Albersen, M., Boelen, A., Kluijtmans, L. A. J., Visser, W. F., de Vries, M. C., Bosch, A. M., C5-OH NBS Working Group, Keularts, I., Panis, B., & Gozalbo, E. R. (2025). Evaluation of Newborn Screening for Diseases Using C5-OH as a Marker: Systematic Review of the Literature and Evaluation of 17 Years of C5-OH Screening in the Netherlands. Journal of Inherited Metabolic Disease, 48(5), Article e70088. https://doi.org/10.1002/jimd.70088

Fragasso, G., Stolfo, D., Anker, M. S., Bayes-Genis, A., Chioncel, O., Heymans, S., Jhund, P. S., Lewis, B. S., Lopaschuk, G. D., Lund, L. H., Gonzalez, A., Pagnesi, M., Schiattarella, G. G., Tocchetti, C. G., van Der Meer, P., Von Linthout, S., Wassmann, S., Westenbrink, B. D., Metra, M., ... Savarese, G. (2025). The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC. European journal of heart failure, 27(9), 1700-1719. https://doi.org/10.1002/ejhf.3703

Schoonvelde, S. A. C., Zwetsloot, P.-P., Hirsch, A., Schinkel, A. F. L., Knackstedt, C., Germans, T., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., & Michels, M. (2025). Accelerometry-defined physical activity and quality of life in hypertrophic cardiomyopathy. Heart, Article 326217. https://doi.org/10.1136/heartjnl-2025-326217

Geraeds, C. B. G., Bruninx, A., Dekker, A. L. A. J., Barandiaran Aizpurua, A., Bermejo, I., & Brunner-La Rocca, H.-P. (2025). Exploring safety of down-titrating diuretics in heart failure management. European journal of heart failure, 27(8), 1393-1399. https://doi.org/10.1002/ejhf.3714

Weerts, J., Schroen, B. L. M., Barandiaran Aizpurua, A., Berendschot, T. T. J. M., Brandts, L., Webers, C. A. B., Simons, S. O., Meex, S. J. R., Henry, R., van der Kallen, C. J. H., Brunner-La Rocca, H.-P., Knackstedt, C., Heymans, S. R. B., de Boer, R. A., van Empel, V. P. M., & Houben, A. J. H. M. (2025). Microvascular dysfunction across organs in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study. Cardiovascular Diabetology, 24(1), Article 310. https://doi.org/10.1186/s12933-025-02850-1

Venner, M. F. G. H. M., Gevers, T. J. G., Ploum, F., Habets, J., Raafs, A. G., Weerts, J., Heymans, S. R. B., van der Leij, C., de Haan, M. W., Verdonschot, J. A. J., Kramer, M., & Knackstedt, C. (2025). Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation. International Journal of Cardiology, 431, Article 133226. https://doi.org/10.1016/j.ijcard.2025.133226

Wong, L. Y., Torfs, T., Vanherle, S. J. V., Janssen, J., Claes, G. R. F., Stroeks, S. L. V. M., Willemars, M. M. A., Schianchi, F., Kapsokalyvas, D., Weltjens, E., Swinnen, A., Strzelecka, A., Krapels, I. P. C., Heymans, S. R. B., Glatz, J., van den Wijngaard, A., Brunner, H. G., Broers, J., Luiken, J. F. P., ... Nabben, M. (2025). Clinical and metabolic consequences of a historic pathogenic lamin A/C founder variant. Scientific Reports, 15(1), Article 23842. https://doi.org/10.1038/s41598-025-08495-0

Steiner, B., Verket, M., Baldewijns, K., Murphy, M., McNulty, A., Schwertfeger, M., Friedl, S., Barrett, M., Hill, L., Brandts, J., Romero, I., Helms, T. M., Brunner-La Rocca, H.-P., Zippel-Schultz, B., & iCARE4CVD Consortium (2025). Participative research for individualised care in cardiovascular diseases (PRIC-CVD): study protocol for a non-interventional, multicentre mixed-methods study as part of iCARE4CVD. BMJ Open, 15(7), Article e098061. https://doi.org/10.1136/bmjopen-2024-098061

Kerneis, M., Ammirati, E., Delmas, C., Heggermont, W., Heymans, S., Lenz, M., Madonna, R., Morosin, M., Schaubroeck, H., Sionis, A., Tsaban, G., Uzokov, J., Vardanyan, K., Vandenbriele, C., & Roubille, F. (2025). Clinical Management of Acute myocarditis in daily practice: an expert practical view. European Heart Journal: Acute Cardiovascular Care, 14(7), 420-431. https://doi.org/10.1093/ehjacc/zuaf057

Malgie, J., Wilde, M. I., Brunner-La Rocca, H.-P., Emans, M. E., De Boer, G. A., Siegers, C. E. P., van Stipdonk, A. M. W., Wardeh, A. J., Schaap, J., Sanders-van Wijk, S., van den Heuvel, M., Wierda, E., De Boer, R. A., Koudstaal, S., & Brugts, J. J. (2025). Newly diagnosed heart failure with reduced ejection fraction: timing, sequencing, and titration of guideline-recommended medical therapy. European Heart Journal, 46(25), 2394-2405. https://doi.org/10.1093/eurheartj/ehaf244

Raman, J., Simmonds, S. J., Caluwé, E., van Leeuwen, R., Walschap, C., Stroobants, M., Cöl, Ü., Vandervoort, P., Heymans, S., & Jones, E. A. V. (2025). Ccr2+ Monocyte-Derived Macrophages Drive Cardiac Hypertrophy In Early Hfpef. American Journal of Physiology-heart and Circulatory Physiology, 329(1), H109-H123. https://doi.org/10.1152/ajpheart.00022.2025

Gingele, A. J., Steiner, B., Zippel-Schultz, B., & Brunner-La Rocca, H.-P. (2025). Adherence to eHealth Interventions Among Patients With Heart Failure: Scoping Review. JMIR mHealth and uHealth, 13, Article e63409. https://doi.org/10.2196/63409

Brunner-La Rocca, H.-P., Mueller-Wieland, D., Hovingh, G. K., & iCARE4CVD Consortium Investigators (2025). iCARE4CVD: an innovative European consortium aiming to improve personalized cardiovascular care. European Heart Journal, 46(23), 2139-2141. Article ehaf128. https://doi.org/10.1093/eurheartj/ehaf128

Weerts, J., Mourmans, S. G. J., Lopez-Martinez, H., Domingo, M., Aizpurua, A. B., Henkens, M. T. H. M., Achten, A., Lupon, J., Brunner-La Rocca, H.-P., Knackstedt, C., Bayes-Genis, A., & van Empel, V. P. M. (2025). Inter-atrial block as a predictor of adverse outcomes in patients with HFpEF. Esc heart failure, 12(3), 2287-2297. https://doi.org/10.1002/ehf2.15179

Herrmann, J. J., Brunner-La Rocca, H.-P., Baltussen, L. E. H. J. M., Beckers-Wesche, F., Bekkers, S. C. A. M., Bellersen, L., van Eck, J. W. M., Hassing, H. C., Jaarsma, T., Linssen, G. C. M., Pisters, R., Sanders-van Wijk, S., Verdijk, M. H. I., Handoko, M. L., van der Meer, P., Verbrugge, F. H., Januzzi Jr, J. L., Bayes-Genis, A., Nieuwlaat, R., ... van Kimmenade, R. R. J. (2025). Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial. Nature Medicine, 31(6), 2062-2068. https://doi.org/10.1038/s41591-025-03628-4

Achten, A., van Empel, V. P. M., Weerts, J., Mourmans, S., Brunner-La Rocca, H.-P., Sanders-van Wijk, S., & Knackstedt, C. (2025). Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fraction. Netherlands Heart Journal, 33(6), 193-198. https://doi.org/10.1007/s12471-025-01954-3

Helms, T. M., Boriani, G., Brunner-La Rocca, H.-P., Klein, C., Koehler, F., Krzesinski, P., Maaser, Y., Neumann, A., Merino, J. L., Schultz, C., Wright, D. J., Zippel-Schultz, B., & Hindricks, G. (2025). The present and future of cardiological telemonitoring in Europe: a statement from seven European countries. Herzschrittmachertherapie und Elektrophysiologie, 36(2), 138-148. https://doi.org/10.1007/s00399-025-01076-8

Ghigo, A., Ameri, P., Asnani, A., Bertero, E., de Boer, R. A., Farmakis, D., González, A., Heymans, S., Ibáñez, B., López-Fernández, T., Lyon, A. R., Pollesello, P., Rakisheva, A., Stellos, K., Streckfuss-Bömeke, K., Tocchetti, C. G., Thum, T., van der Meer, P., Van Rooij, E., ... Van Linthout, S. (2025). Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart. European journal of heart failure, 27(6), 1028-1046. https://doi.org/10.1002/ejhf.3636

Wiethoff, I., Schoonvelde, S. A. C., de Boer, R. A., Evers, S. M. A. A., Germans, T., Hirsch, A., Knackstedt, C., Te Rijdt, W. P., van Slegtenhorst, M. A., Schinkel, A. F. L., Zwetsloot, P.-P., Michels, M., & Hiligsmann, M. (2025). Assessing the psychometric properties of generic (EQ-5D-5L) and disease-specific (KCCQ) quality of life in patients with hypertrophic cardiomyopathy in the AFFECT-HCM study. Open Heart, 12(1), Article e003143. https://doi.org/10.1136/openhrt-2024-003143

Michel, L. Y. M., Esfahani, H., De Mulder, D., Verdoy, R., Ambroise, J., Roelants, V., Bouchard, B., Fabian, N., Savary, J., Dewulf, J. P., Doumont, T., Bouzin, C., Haufroid, V., Luiken, J. J. F. P., Nabben, M., Singleton, M. L., Bertrand, L., Ruiz, M., Des Rosiers, C., & Balligand, J.-L. (2025). An NRF2/β3-Adrenoreceptor Axis Drives a Sustained Antioxidant and Metabolic Rewiring Through the Pentose-Phosphate Pathway to Alleviate Cardiac Stress. Circulation, 151(18), 1312-1328. https://doi.org/10.1161/CIRCULATIONAHA.124.067876